All studies
Ongoing, recruitingTherapeutic exploratory (Phase II)Interventional
A PHASE 2 MULTICENTER STUDY OF AXICABTAGENE CILOLEUCEL IN SUBJECTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA (INHL)
At a glance
Status
Ongoing, recruiting
Phase
Therapeutic exploratory (Phase II)
Sponsor
Kite Pharma Inc.
Enrolment target
10
Start
26 Sep 2023
What is this study about?
Objective response rate (ORR) per central read for up to 15 years
Who may be eligible?
Age 18 Years to any · Sex: All
Locations (1)
- —France
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.